Global Dental Biomaterials Market - 2022-2029

Global Dental Biomaterials Market - 2022-2029

Market Overview

The Dental Biomaterials Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.7% during the forecast period (2022-2029)

Dental biomaterials are specialized natural or synthetic products designed to be used in preventive and restorative dentistry. These products are used to restore damaged, decayed, or fractured teeth. Dental biomaterials are efficient products with a high success rate in oral treatment and prevention. These products replace the damaged or missing tooth tissues and also promote tissue regeneration. Natural biomaterials include enamel, dentin, cementum, bone, and other intraoral tissues and synthetic materials include metals, ceramics, polymers, and composite structures.

Market Dynamics

The market is driven by the growing prevalence of dental disorders, rising geriatric population, increasing demand for cosmetic dentistry, increase in expenditure on dental and oral care, and increasing adoption of novel adhesives, resin cement in CAD/CAM, and other digital technologies.

The increasing prevalence of oral disorders is expected to drive market growth.

Oral disorders such as periodontal disease, tooth decay, oral cancer, dental caries, and halitosis, among others, are driving the market growth. According to the Centers for Disease Control and Prevention (CDC), indications of gum disease are present in 46 percent of all persons aged 30 and older, with serious gum disease affecting approximately 9% of adults. Untreated dental decay affects approximately 26% of persons in the United States. Furthermore, according to the National Institute of Dental and Craniofacial Research, 92 percent of adults aged 20 to 64 have dental caries in their permanent teeth, with an average severity of 3.28 decayed or missing permanent teeth and 13.65 decaying and missing permanent teeth. Increased awareness of the significance of dental implants in middle and low-income nations will drive market growth throughout the forecast period. Aside from that, as disposable income in industrialized countries has increased, so has demand for aesthetic procedures like teeth whitening and gum contouring. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

High cost of treatment, presence of stringent regulatory and clinical processes, and low reimbursement coverage by insurance are going to restrain the market in the forecast period.

Industry Analysis

The dental biomaterials market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis/B>

Polymeric Biomaterials segment is expected to hold the largest market share in the dental biomaterials market.

The polymeric biomaterials segment accounted for the largest market share in 2021. The segment benefits because of high product durability, reduced risks of infections compared to other materials, material flexibility that provides ease in shape formation, biocompatibility, good resilience, lightweight, easy fabrication, and high corrosion resistance. Moreover, polymeric biomaterials have unique antimicrobial and drug delivery properties in preventive, regenerative, and restorative therapies to reduce friction and corrosion in dentistry. Therefore, it has increased the demand for polymeric biomaterials. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

North American region is expected to hold the largest market share in the global dental biomaterials market.

The North American region accounted for the largest market share in 2021. Owing to the increasing prevalence of caries and the presence of major players within the region, high dental expenditure within the Americas are the factors to drive the market growth. For instance, according to a recent paper by the American College of Prosthodontists, more than 36 million Americans are toothless, and 120 million have at least one missing tooth. Such circumstances in the Americas increase the demand for prosthodontics and implants. Moreover, Pulpdent Corporation, a dental research and manufacturing business in the Greater Boston area, launched ACTIVA Presto dental material in January 2020. The new white dental filling material has qualities similar to natural teeth. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the dental biomaterials market are Straumann AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Kuraray Co., Ltd, Medtronic Plc., Henry Schein, Inc., Mitsui Chemicals, Inc., Victrex Plc, Ivoclar Vivadent AG, GC Corporation, Keystone Dental, Inc., Datum Dental Ltd, BEGO Medical GmbH, Cam Bioceramics B.V., Geistlich Pharma AG, BioHorizons IPH, Inc., and Biomatlante.

Straumann:

Straumann is a global leader in implant, restorative and regenerative dentistry. The company researches, develop, and manufacture dental implants, instruments, prosthetics, and tissue and bone regeneration biomaterials in collaboration with leading clinics, research institutes, and universities for tooth replacement and restoration or to prevent tooth loss. The company has six production sites for implants, biomaterials and CAD/CAM in Europe, the United States and Japan. Its extensive network of distribution subsidiaries and partners makes its products and services available in over 70 countries. The company’s periodontal product portfolio includes Straumann Emdogain FL, leading to true periodontal regeneration based on biomimicry.

Product Portfolio:

Straumann XenoFlex: Straumann XenoFlex is a biomimetric composite material that resembles the native bone in its basic biphasic composition of collagen and xenogenic hydroxyapatite. It has beneficial handling characteristics and the ability to be shaped to match the individual defect situation. Straumann XenoFlex – an efficient, easy to handle, volume stable solution for the treatment of bone defects.

The global dental biomaterials market report would provide an access to an approx. 45+market data table, 40+figures